Determinants of and barriers to diabetes care among patients with serious mental illness: A scoping review with recommendations

IF 4.3 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes & Metabolic Syndrome-Clinical Research & Reviews Pub Date : 2024-10-01 DOI:10.1016/j.dsx.2024.103139

A.S. Prathiksha , Pawar Mansi Shantaram , Muhammed Rashid , Pooja Gopal Poojari , Sreedharan Nair , Leelavathi D. Acharya , Girish Thunga

{"title":"Determinants of and barriers to diabetes care among patients with serious mental illness: A scoping review with recommendations","authors":"A.S. Prathiksha , Pawar Mansi Shantaram , Muhammed Rashid , Pooja Gopal Poojari , Sreedharan Nair , Leelavathi D. Acharya , Girish Thunga","doi":"10.1016/j.dsx.2024.103139","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><div>We performed a scoping review to identify the diabetes care determinants and barriers in patients with serious mental illness (SMI), in view of limited evidence and clarity.</div></div><div><h3>Methods</h3><div>We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Guidelines. PubMed, EMBASE, and Scopus were searched from inception to September 2023 to identify eligible studies. Observational studies that reported the determinants of and barriers to diabetes care among SMI patients were considered. A narrative synthesis of review results was performed to gather evidence. Recommendations were framed in the context of this evidence.</div></div><div><h3>Results</h3><div>Of the 8727 non-duplicate records, only 10 studies that met the inclusion criteria were considered for this review. Of these, four were cohort, two were case-control, and four were cross-sectional in design. All 10 studies were observed to have robust methodologies. Diabetes measures examined in these studies included not only the Healthcare Effectiveness Data and Information Set (HEDIS) measures (HbA1c, retinopathy, nephropathy, and blood pressure), but also lipid, foot, and BMI. Factors contributing to inadequate diabetes care can be attributed to the healthcare system, healthcare providers, and at the patient-level.</div></div><div><h3>Conclusion</h3><div>Currently, there is lack of evidence on determinants of quality diabetes care among SMI patients. Further, adequately powered long term follow-up studies are needed to understand the impact of diabetes care on their clinical outcomes.</div></div>","PeriodicalId":48252,"journal":{"name":"Diabetes & Metabolic Syndrome-Clinical Research & Reviews","volume":"18 10","pages":"Article 103139"},"PeriodicalIF":4.3000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes & Metabolic Syndrome-Clinical Research & Reviews","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1871402124002005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Aim

We performed a scoping review to identify the diabetes care determinants and barriers in patients with serious mental illness (SMI), in view of limited evidence and clarity.

Methods

We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Guidelines. PubMed, EMBASE, and Scopus were searched from inception to September 2023 to identify eligible studies. Observational studies that reported the determinants of and barriers to diabetes care among SMI patients were considered. A narrative synthesis of review results was performed to gather evidence. Recommendations were framed in the context of this evidence.

Results

Of the 8727 non-duplicate records, only 10 studies that met the inclusion criteria were considered for this review. Of these, four were cohort, two were case-control, and four were cross-sectional in design. All 10 studies were observed to have robust methodologies. Diabetes measures examined in these studies included not only the Healthcare Effectiveness Data and Information Set (HEDIS) measures (HbA1c, retinopathy, nephropathy, and blood pressure), but also lipid, foot, and BMI. Factors contributing to inadequate diabetes care can be attributed to the healthcare system, healthcare providers, and at the patient-level.

Conclusion

Currently, there is lack of evidence on determinants of quality diabetes care among SMI patients. Further, adequately powered long term follow-up studies are needed to understand the impact of diabetes care on their clinical outcomes.

查看原文本刊更多论文

重症精神病患者接受糖尿病护理的决定因素和障碍：范围界定审查及建议

目的鉴于证据有限且不明确，我们进行了一项范围界定综述，以确定严重精神疾病（SMI）患者的糖尿病护理决定因素和障碍。方法我们遵循了《范围界定综述的系统综述和元分析首选报告项目》（PRISMA-ScR）指南。我们检索了从开始到 2023 年 9 月的 PubMed、EMBASE 和 Scopus，以确定符合条件的研究。研究考虑了报告 SMI 患者糖尿病护理的决定因素和障碍的观察性研究。对综述结果进行了叙述性综合，以收集证据。结果在 8727 条非重复记录中，仅有 10 项符合纳入标准的研究被纳入本次综述。其中，4 项为队列研究，2 项为病例对照研究，4 项为横断面研究。据观察，所有 10 项研究都采用了可靠的方法。这些研究中考察的糖尿病指标不仅包括医疗保健有效性数据和信息集（HEDIS）指标（HbA1c、视网膜病变、肾病和血压），还包括血脂、足部和体重指数。导致糖尿病护理不足的因素可归因于医疗保健系统、医疗保健提供者以及患者层面。此外，还需要进行充分的长期跟踪研究，以了解糖尿病护理对其临床疗效的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes & Metabolic Syndrome-Clinical Research & Reviews ENDOCRINOLOGY & METABOLISM-

CiteScore

22.90

自引率

2.00%

发文量

248

审稿时长

51 days

期刊介绍： Diabetes and Metabolic Syndrome: Clinical Research and Reviews is the official journal of DiabetesIndia. It aims to provide a global platform for healthcare professionals, diabetes educators, and other stakeholders to submit their research on diabetes care. Types of Publications: Diabetes and Metabolic Syndrome: Clinical Research and Reviews publishes peer-reviewed original articles, reviews, short communications, case reports, letters to the Editor, and expert comments. Reviews and mini-reviews are particularly welcomed for areas within endocrinology undergoing rapid changes.